GNA12 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.353000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.750400E-01
Normal-vs-Stage2
5.796200E-01
Normal-vs-Stage3
2.042800E-01
Normal-vs-Stage4
5.400200E-01
Stage1-vs-Stage2
4.100600E-01
Stage1-vs-Stage3
3.555000E-01
Stage1-vs-Stage4
6.424000E-01
Stage2-vs-Stage3
4.743000E-01
Stage2-vs-Stage4
9.918000E-01
Stage3-vs-Stage4
5.078000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.480000E-01
Normal-vs-AfricanAmerican
8.709400E-01
Normal-vs-Asian
2.348400E-01
Caucasian-vs-AfricanAmerican
6.436800E-01
Caucasian-vs-Asian
2.519400E-01
AfricanAmerican-vs-Asian
1.802380E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.966600E-01
Normal-vs-Female
8.621400E-01
Male-vs-Female
7.939700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.780600E-01
Normal-vs-Age(41-60Yrs)
9.273800E-01
Normal-vs-Age(61-80Yrs)
3.257000E-01
Normal-vs-Age(81-100Yrs)
4.849800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.198200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.433400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.434200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.497700E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.134800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.587200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.594750E-01
Normal-vs-Daily Drinker
2.853800E-01
Normal-vs-Weekly Drinker
8.949800E-01
Normal-vs-Occasional Drinker
7.617800E-01
Normal-vs-Social Drinker
9.391600E-01
Non Drinker-vs-Daily Drinker
4.413000E-01
Non Drinker-vs-Weekly Drinker
1.865950E-01
Non Drinker-vs-Occasional Drinker
3.945600E-02
Non Drinker-vs-Social Drinker
1.185560E-02
Daily Drinker-vs-Weekly Drinker
2.890000E-01
Daily Drinker-vs-Occasional Drinker
1.851990E-01
Daily Drinker-vs-Social Drinker
6.603600E-02
Weekly Drinker-vs-Occasional Drinker
6.017600E-01
Weekly Drinker-vs-Social Drinker
8.415600E-01
Occasional Drinker-vs-Social Drinker
5.304000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.644600E-01
Normal-vs-Grade 2
6.451600E-01
Normal-vs-Grade 3
6.508400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.733600E-01
Grade 1-vs-Grade 3
5.567200E-01
Grade 1-vs-Grade 4
6.644600E-01
Grade 2-vs-Grade 3
6.339400E-01
Grade 2-vs-Grade 4
6.451600E-01
Grade 3-vs-Grade 4
6.508400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.866000E-01
Normal-vs-NonDiabetic
6.694400E-01
Diabetic-vs-NonDiabetic
5.969000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.156000E-01
Normal-vs-NoPancreatitis
6.548600E-01
Pancreatitis-vs-NoPancreatitis
8.443000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.108400E-01
Normal-vs-N1
6.124400E-01
N0-vs-N1
8.149200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.520000E-01
Normal-vs-TP53-NonMutant
4.261000E-01
TP53-Mutant-vs-TP53-NonMutant
3.149400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
